Sumitomo Pharma America

Sumitomo Pharma America Inc.
Formerly
  • Sepracor, Inc. (1984 - 2010)
  • Sunovion Pharmaceuticals Inc. (2010-2023)
TypeSubsidiary
Nasdaq: SEPR (1991 - 2009)
IndustryPharmaceuticals
Predecessor
  • Sumitomo Pharma America Holdings
  • Sumitomo Pharma Oncology
  • Sumitovant Biopharma
  • Myovant Sciences
  • Urovant Sciences
  • Enzyvant Sciences
Founded1984 (1984) (as Sepracor)
HeadquartersMarlborough, Massachusetts, United States
Key peopleTsutomu Nakagawa (President and CEO)
ProductsLatuda
Aptiom
Kynmobi
Lonhala Magnair
Lunesta
ParentSumitomo Pharma
Websitehttps://www.us.sumitomo-pharma.com

Sumitomo Pharma America Inc. is the American subsidiary of Japanese pharmaceutical company Sumitomo Pharma. It was originally founded in 1984 as Sepracor. In 2010, it was acquired by Sumitomo Dainippon Pharma as a standalone subsidiary and was renamed Sunovion Pharmaceuticals. In 2023, seven Sumitomo subsidiaries were restructured into Sunovion, which was subsequently renamed to Sumitomo Pharma America.

The corporation focuses on therapeutic areas of psychiatry and neurology, oncology, urology, and women's health.